High myopia increases the risk of blinding eye conditions, so regular follow-up is essential. At Clarity Optical, we understand your concern with Myopia progression and we make it a priority for prevention and treatment. With the right treatment & plan we an help you slow down that progression.
How to prevent myopia?
Many recent studies state that giving children and yourself more time for outdoor activities at least 1 hour a day can prevent myopia development, and can reduce the risk of myopia by 30%.
Ortho-K or overnight contact lenses are the most effective optical treatment for myopia control. Studies show continuous wearing of Ortho-K lenses can slow myopia progression by 40-60%.
MiyoSmart lenses are innovative spectacle lenses for myopia control developed by Hoya. With (D.I.M.S) technology work to curb myopia progression average by 60%*. It also decreased axial elongation on average by 60% compared with those wearing single vision lenses.
Atropine Eye Drops
Recent studies state that using low dose of atropine eye drops 0.01%. 0.02%, 0.05% which are topical pharmaceutical method of reducing the progression of myopia. But more research are needed for knowing about the side effects of long-term use of atropine.
MiSight Contact Lenses
MiSight 1 Day is the first soft daily disposable contact lens worn during the day only and is suitable for those who don’t feel comfortable wearing contact lenses to sleep. It is also effective in slowing myopia progression by 50-60% when compared to conventional single vision contact lenses.
Schedule an appointment with one of our optometrists today to find out more about what myopia control treatment can do for you. The Link is in our Bio.
Prevalence of myopia in Hong Kong
– Lam CS et al. Prevalence of myopia among Hong Kong Chinese schoolchildren: changes over two decades. Ophthalmic Physiol Opt, 2012; 32(1): 17-24.
– Lam CSY & Goh WSH. The incidence of refractive errors among school children in Hong Kong and its relationship with the optical components. Clin Exp Optom, 1991; 74: 97-103.
Factors for myopia development
– Jones LA et al. Parental history of myopia, sports and outdoor activities, and future myopia. Invest Ophthalmol Vis Sci, 2007; 48(8): 3524-32.
– Kurtz D et al. Role of parental myopia in the progression of myopia and its interaction with treatment in COMET children. Invest Ophthalmol Vis Sci, 2007; 48(2): 562-70.
– Parssinen O, Lyyra AL. Myopia and myopic progression among schoolchildren: a three-year follow-up study. Invest Ophthalmol Vis Sci, 1993; 34: 2794-802.
– Ip JM, Saw SM, Rose KA et al. Role of near work in myopia: findings in a sample of Australian school children. Invest Ophthalmol Vis Sci, 2008; 49: 2903-10.
Time outdoors vs myopia
– Deng L, Gwiazda J, Thorn F. Children’s refractions and visual activities in the school year and summer. Optom Vis Sci, 2010; 87: 406-13.
– Dirani M, Tong L, Gazzard G et al. Outdoor activity and myopia in Singapore teenage children. Br J Ophthalmol, 2009; 93: 997-1000.
Myopia control using prismatic bifocal
– Cheng D, Schmid KL, Woo GC, Drobe B. Randomized trial of effect of bifocal and prismatic bifocal spectacles on myopic progression: two-year results. Arch Ophthalmol, 2010; 128: 12-19.
– Cheng D, Woo GC, Drobe B, Schmid KL. Effect of bifocal and prismatic bifocal spectacles on myopia progression in children: three-year results of a randomized clinical trial. JAMA Ophthalmol, 2014; 132: 258-264.
Myopia control using orthokeratology
– Cho P, Cheung SW, Edwards M. The Longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res, 2005; 30: 71-80.
– Cho P, Cheung SW. Retardation of myopia in orthokeratology (ROMIO) study: a 2-year randomized Clinical Trial. Invest Ophthalmol Vis Sci, 2012; 53: 7077-7085.
Myopia control using DISC lens
– Lam CSY, Tang WC, Tse DY, Tang YY, To CH. Defocus incorporated soft contact (DISC) lens slow myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomized clinical trial. Br J Ophthalmol, 2014; 98: 40-45.
Myopia control using atropine
– Chua WH, Balakrishnan V, Chan YH et al. Atropine for the treatment of childhood myopia. Ophthalmology, 2006; 113: 2285-91.
– Chia A, Chua WH, Cheung YB et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (ATOM2). Ophthalmology, 2012; 119: 347-54.